Oligoclonal T cell expansions in pulmonary lymphoproliferative disorders: demonstration of the frequent occurrence of oligoclonal T cells in human immunodeficiency virus-related lymphoid interstitial pneumonia.
Oligoclonal T cell expansions in pulmonary lymphoproliferative disorders: demonstration of the frequent occurrence of oligoclonal T cells in human immunodeficiency virus-related lymphoid interstitial pneumonia.
复制标题
肺淋巴增殖性疾病中的寡克隆 T 细胞扩增:证明寡克隆 T 细胞在人类免疫缺陷病毒相关淋巴样间质性肺炎中频繁发生。
DOI:
10.1164/ajrccm.165.2.2101141
复制
发表时间:
2002
期刊:
影响因子:
--
通讯作者:
Weiden,MichaelD
中科院分区:
文献类型:
--
作者:
Kurosu,Katsushi;Yumoto,Norio;Rom,WilliamN;Takiguchi,Yuichi;Jaishree,Jagirdai;Nakata,Koh;Tatsumi,Koichiro;Mikata,Aatsuo;Kuriyama,Takatyuki;Weiden,MichaelD
We used a denaturing gradient gel electrophoresis (DGGE) procedure with 40-nucleotide guanine- and cytosine-rich sequences in the polymerase chain reaction (PCR) and sequencing analysis to analyze the T cell antigen receptor (TCR)-V γ gene repertoire of infiltrating T lymphocytes in pulmonary lymphoproliferative disorders. Six of 15 low-grade mucosa-associated lymphoid tissue (MALT) lymphomas and 8 of 15 cases of lymphocytic interstitial pneumonia (LIP) showed some oligoclonal bands for TCR-V γ genes on DGGE. Sequencing analysis demonstrated plural oligoclonal TCR-V γ clones among the oligoclonal PCR products on DGGE, leading to the conclusion that conventional antigen-specific oligoclonal expansions may play some role in the pathogenesis of pulmonary lymphoproliferative disorders. The frequency of oligoclonal infiltrating T cell expansions in human immunodeficiency virus (HIV)-related LIP (100%) was significantly higher than in low-grade pulmonary MALT lymphomas (40%) or in HIV-negative LIP (30%). Because recent evidence demonstrates that the V3 loop in the proviral amino acid sequences of mononuclear cells from bronchoalveolar lavage is more homogeneous than those from peripheral blood, this homogeneity might result in oligoclonal expansions of infiltrating T lymphocytes as a consequence of ongoing reactions against lung-specific viral strains.